HomeEstonia-StartupsEstonian migraine treatment app Migrevention completes pre-seed round and enters clinical trial

Estonian migraine treatment app Migrevention completes pre-seed round and enters clinical trial

Founded in 2020, Migrevention is an Estonian startup on a mission to develop a digital health solution to allow for remote treatment of migraine. In its pre-seed round, the healthtech startup raised €355k. The funding was led by Dag Nurm alongside other investors experienced in healthcare, tech, legal and startup sectors. 

With a core team made up of neurologists and psychologists, as well as long term migraine patients, Migrevention plans to evolve as a platform for scientifically proven treatment. The first part of the application was launched earlier this year and the young company recently launched clinical trials at Tartu University Hospital. 

Globally more than 1 billion people suffer from frequent migraine attacks – but only 1-4% of patients receive adequate treatment in specialised headache clinics. Migraines are thus largely an invisible malady many people are suffering. 

Katrina Laks, founder and CEO, stated: “Our solution allows us to help 10 times more headache patients thus offering a future treatment option to anyone suffering from frequent migraine headaches. We are developing a solution that would allow to monitor and prevent headache episodes, as well as offer treatment based on science-based recommendations.”

In March 2021, the startup launched its digital headache diary – marking an integral part of the treatment journey. Together with the clinical trials, Migrevention is combining digital intervention with conventional treatment with the goal to certify the product as a digital medical device this year. 

Migrevention’s solution offers a series of digital treatment options from patients that can be quickly and easily accessed from the comfort of home via the app. It also offers digital tools for specialists to reduce their work time and expedite the ability to assess patients conditions through evidence-based migraine treatments. 

The implementation of the Migrevention project “Development of the Migrevention digital headache clinic” has also been supported by the Estonian-Norwegian cooperation program “Green ICT”.

Patricia Allen
Patricia Allen
is the Head of Content at EU-Startups. With a background in politics, Patricia has a real passion for how shared ideas across communities and cultures can bring new initiatives and innovations for the future. She spends her time bringing you the latest news and updates of startups across Europe, and curating our social media.

Most Popular